Literature DB >> 26223920

Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.

Lin Wu1, Pi-Qi Zhou1, Ji-Wen Xie1, Rui Zhu2, Sun-Chang Zhou3, Geng Wang4, Zhong-Xu Wu5, Sha Hao1.   

Abstract

In order to investigate whether Yinchenhao decoction (YCHD) attenuates hepatic fibrogenesis in the bile duct ligation (BDL) model via recovering and restoring the self-regulation and balance of the renin-angiotensin system (RAS), 33 specific-pathogen-free (SPF) male Sprague-Dawley rats with common BDL and scission were randomly divided into five groups as follows: G1, the sham group (n=4); G2, BDL 7-day group (n=5); G3, BDL+YCHD 430 mg/mL (n=8); G4, BDL+losartan 0.65 mg/mL (ARB group, n=8); G5, model group (BDL without any treatment, n=8). YCHD and losartan (10 mL·kg(-1)·day(-1)) were given by gastric gavage for 16 days following BDL in G3 and G4 groups, respectively. The effect of YCHD on liver fibrosis and the detailed molecular mechanisms were assessed by liver function including total bilirubin (TBIL), direct bilirubin (DBIL), indirect bilirubin (IDBIL), alanine aminotransferase (ALT), and aspartate aminotransferase (AST). Histological changes were observed by transmission electron microscopy (TEM) and Masson trichrome staining. Western blotting was used to detect the protein expression level of the renin-angiotensin system (RAS) components including angiotensin converting enzyme (ACE), angiotensin II type 1 receptor (AT1R), ACE2, angiotensin II (AngII) as well as transforming growth factor β1 (TGFβ1). The experimental data were analyzed by principle component analytical method of pattern recognition. The results showed that biochemically, serum TBIL, DBIL, IDBIL, ALT and AST levels were markedly increased following BDL as compared with the sham group (P<0.05). Serum TBIL, IDBIL and DBIL levels in G3 group were dramatically decreased as compared with G5 and G4 groups (P<0.05). Serum AST level in G3 was significantly lowered than in G5 group (P<0.05), but there was no significant difference in ALT among G3, G4 and G5 groups (P>0.05). Histologically, livers in G3 group showed less hepatocytes necrosis, less bile duct hyperplasia and less collagen formation than in G4 and G5 groups. The protein expression levels of ACE2, ACE, AngII, AT1R and TGFβ1 in G2, G3 and G4 groups were significantly higher than in sham group (P<0.05), and lower than in G5 group (P<0.05). However, the differences among G2, G3 and G4 groups were not significant (P>0.05). ACE2 protein expression in G3 group was significantly higher than in G2 group (P<0.05) and there was no significant difference in comparison with G4 group (P>0.05). Moreover, the protein expression of TGFβ1 in G3 group was significantly lower than in G5 and G4 groups (P<0.05). Our findings suggest that the antifibrotic effects of YCHD may be associated with the decreased classical RAS pathway components and TGFβ1 downexpression so as to recover and rebuild self-regulation of the RAS by elevating the protein expression of ACE2.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26223920     DOI: 10.1007/s11596-015-1463-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  21 in total

1.  Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver.

Authors:  Georgina Paizis; Mark E Cooper; Josefa M Schembri; Christos Tikellis; Louise M Burrell; Peter W Angus
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.

Authors:  G Paizis; C Tikellis; M E Cooper; J M Schembri; R A Lew; A I Smith; T Shaw; F J Warner; A Zuilli; L M Burrell; P W Angus
Journal:  Gut       Date:  2005-09-15       Impact factor: 23.059

Review 3.  The role of the renin-angiotensin system in liver fibrosis.

Authors:  M Kamruzzman Munshi; Mohammad N Uddin; Shannon S Glaser
Journal:  Exp Biol Med (Maywood)       Date:  2011-04-20

4.  Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis.

Authors:  Qian Huang; Qing Xie; Cui-Cui Shi; Xiao-Gang Xiang; Lan-Yi Lin; Bang-Dong Gong; Gang-De Zhao; Hui Wang; Ni-Na Jia
Journal:  Int J Mol Med       Date:  2009-06       Impact factor: 4.101

5.  Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

Authors:  Christoph H Osterreicher; Kojiro Taura; Samuele De Minicis; Ekihiro Seki; Melitta Penz-Osterreicher; Yuzo Kodama; Johannes Kluwe; Manfred Schuster; Gavin Y Oudit; Josef M Penninger; David A Brenner
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

6.  Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats.

Authors:  En-tong Yi; Rui-xia Liu; Yan Wen; Cheng-hong Yin
Journal:  Acta Pharmacol Sin       Date:  2012-10-29       Impact factor: 6.150

7.  Up-regulation of components of the renin-angiotensin system in liver fibrosis in the rat induced by CCL₄.

Authors:  Wei Zhang; Jinfeng Miao; Pengfei Li; Yanxia Wang; Yuanshu Zhang
Journal:  Res Vet Sci       Date:  2013-02-21       Impact factor: 2.534

8.  Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats.

Authors:  Cheng Liu; Mingyu Sun; Lei Wang; Gaoqiang Wang; Gaofeng Chen; Chenghai Liu; Ping Liu
Journal:  Chin Med       Date:  2008-01-31       Impact factor: 5.455

9.  Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis.

Authors:  Chandana B Herath; Fiona J Warner; John S Lubel; Rachael G Dean; Zhiyuan Jia; Rebecca A Lew; A Ian Smith; Louise M Burrell; Peter W Angus
Journal:  J Hepatol       Date:  2007-04-02       Impact factor: 25.083

Review 10.  Renin-angiotensin system revisited.

Authors:  F Fyhrquist; O Saijonmaa
Journal:  J Intern Med       Date:  2008-09       Impact factor: 8.989

View more
  3 in total

Review 1.  Herbal medicines and nonalcoholic fatty liver disease.

Authors:  Hong Yao; Yu-Jie Qiao; Ya-Li Zhao; Xu-Feng Tao; Li-Na Xu; Lian-Hong Yin; Yan Qi; Jin-Yong Peng
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 2.  Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis.

Authors:  Fa-Da Wang; Jing Zhou; En-Qiang Chen
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

3.  Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway.

Authors:  Yan-Li Wu; Zhong-Lian Li; Xi-Bo Zhang; Hao Liu
Journal:  World J Gastroenterol       Date:  2019-11-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.